IVIG and rituximab in antibody-associated psychosis - SINAPPS2
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Sweden.
In StockholmThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Denmark.
In AarhusThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.
In BelmontThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In Los AngelesThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Turkey.
In ElâzığThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In ShreveportThis study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ShanghaiThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
Multiple locations, including Vancouver